Distribution of fenofibric acid in lipoprotein fractions of patients

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 2, 1998, Pages 287-294

  Nobilis, M ^a   Kvetina, J ^a   Anzenbacher, P ^a   Vontor, T ^a   Svoboda, D ^a   Bratova M ^b   Solichova D ^b   Zadak Z ^b   Blaha V ^b   Vlcek, J ^c  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Fenofibrate; Fenofibric acid; Fenofibric acid homologues; HPLC determination method; Lipoprotein fractions

Indexed keywords

FENOFIBRATE; FENOFIBRIC ACID; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ACCURACY; ADULT; ANIMAL EXPERIMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DYSLIPIDEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; RODENT;

EID: 17444449199     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189353     Document Type: Conference Paper

References (20)

1. Sornay R., Gurrieri J., Tourne C., Renson F.J., Majoie B. and Wülfert E. (1976): Antilipidemic Drugs. Part 1. Synthesis and structure-activity relationship of new alcoyl and benzoyl phenoxy carboxylic acids. Arzneim.-Forsch., 26, 885-889.
2. Gurrieri J., Le Lous F.J., Renson F.J., et al. (1976): Antilipidemic Drugs. Part 2. Experimental study of a new potent hypolipidemic drug, isopropyl - [4'-(pchlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF 178). Arzneim.-Forsch., 26, 889-894.
3. Rouffy J., Dreux C., Goussault Y., Dakkak R. and Renson F.J. (1976) : Antilipidemic Drugs. Part 5. Evaluation of the hypolipidemic effect of LF-178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV). Arzneim.-Forsch., 26, 901-906.
4. Wülfert E., Majoie B. and de Ceaurriz A. (1976) : Antilipidemic Drugs. Part 6. LF-178 in man. A preliminary note on a multicenter investigation bearing on 393 subjects with pure or mixed forms of hyperlipidemia. Arzneim.Forsch., 26, 906-909.
5. Bertolini S., Elicio N., Daga A., et al. (1988) : Effect of a single daily dose treatment of fenofibrate on plasma lipoproteins in hyperlipoproteinaemia IIb. Eur. J. Clin. Pharmacol., 34, 25-28
6. Chapman M.J. (1987) : Pharmacology of fenofibrate. Am. J. Med., 83 (Suppl. 5B), 21-25
7. Balfour J.A., McTavish D., Hell R.C. (1990) : Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia. Drugs, 40, 260-290
8. Brodie R.R., Chasseaud L.F., Elsom F.F., Franklin E.R. and Taylor T. (1976) : Antilipidemic Drugs. Part 4. The metabolic fate of the hypolipidemic agent isopropyl [4'-(p'Chlorobenzoyl)-2-phenoxy-2-melhyl]-propionate (LF 178) in rats, dog and man. Arzneim.-Forsch., 26, 896-901.
9. Elsom L.F., Hawkins D.R. and Chasseaud L.F. (1976) : Identification of a major metabolite of the new hypolipidaemic agent, isopropyl - [4'-(p-chlorobenzoyl)-2phenoxy-2-methyl]-propionate (procetofene) in humans by GC-MS. J. Chromatogr., 123, 463-467.
10. Cayen M.N. (1985) : Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man. Pharmacol. Ther. 29, 157-204
11. Caldwell J., Strolin-Benedeti M., Weil A. (1986) : Comparative metabolism of fenofibrate in rats and human volunteers. Br. J Clin. Pharmacol. 22, 219P
12. 14C-fenofibrate in human plasma. Acta Pharmacol. Toxicol. 59, 167 (Abstract 456)
13. Weil A., Caldwell J., Strolin-Benedetti M. (1988) : The metabolism and disposition of fenofibrate in rat, guinea pig and dog. Drug Metab. Dispos., 16, 302-309
14. Weil A., Caldwell J., Strolin-Benedetti M. (1990) : The metabolism and disposition of fenofibrate in human volunteers. Drug. Metab. Disp., 18, 115-120
15. Desager J.P. (1978) : GLC determination of procetofenic acid in human plasma and urine. J. Chromatogr., 145, 160-164.
16. Luley C, Kegel H. and Jakobs C. (1981) : Improved method for the determination of procetofenic acid in human plasma by GLC. J. Chromatogr., 224, 500-502
17. Caturla M.C. and Albaigs J. (1982) : Rapid determination of procetofenic acid in plasma by HPLC. J. Chromatogr., 227, 219-222
18. Cotta-Ramusino A. and Carozzi A. (1986) : Simple and rapid method for determining procetofenic acid, an active metabolite of procetofenon, in biological fluids by solid-phase extraction and HPLC. J. Chromatogr., 383, 419-424
19. 14C-fenofibrate in laboratory animals and humans. Chirality, 1, 197-201
20. Kvetina J., Nobilis M., Svoboda Z., Anzenbacher P., Svoboda D., Zadák Z., Bláha V. Havel E. (1998) [Title page 202]: Eur. J. Drug Metab. Pharmacokin., 23 (2): 202-208